Effects of co-administered ezetimibe and fenofibrate in mixed dyslipidaemic patients with metabolic syndrome

被引：0

作者：

Davies, M. J.

Bays, H. E.

Shah, A.

Macdonell, G.

Gumbiner, B.

机构：

[1] Merck & Co Inc, Rahway, NJ 07065 USA

[2] LMARC, Clin Res, Louisville, KY USA

来源：

DIABETOLOGIA | 2006年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0746

引用

页码：452 / 453

页数：2

共 50 条

[1] Effects of co-administered ezetimibe/simvastatin and fenofibrate on lipoprotein subclasses and LDL size pattern in patients with mixed hyperlipidemia
Farnier, M.
Perevozskaya, I. T.
Taggart, W. V.
Kush, D.
Mitchel, Y. B.
ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 209 - 210
[2] Effects of co-administered Ezetimibe/Simvastatin and fenofibrate on lipoprotein subclasses and LDL size pattern in patients with mixed hyperlipidemia
Famier, Michel
Perevozskaya, Inna
Taggart, William
Kush, Debra
Mitchel, Yale
CIRCULATION, 2006, 114 (18) : 289 - 289
[3] Efficacy and safety of co-administered ezetimibe/simvastatin (EZE/SIMVA) and fenofibrate (FENO) in patients with mixed hyperlipidemia
Farnier, M.
Roth, E.
Gil-Extremera, B.
Mendez, G. F.
Perevozskaya, I.
Hamlin, C.
Macdonell, G.
Davies, M.
Kush, D.
Mitchel, Y.
ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 174 - 174
[4] Effects of Coadministered Ezetimibe Plus Fenofibrate in Mixed Dyslipidemic Patients with Metabolic Syndrome
Bays, Harold E.
Shah, Arvind
Macdonell, Geraldine
Taggart, William V.
Gumbiner, Barry
METABOLIC SYNDROME AND RELATED DISORDERS, 2011, 9 (02) : 135 - 142
[5] Effects of coadministered ezetimibe (EZE) and fenofibrate (FENO) in mixed dyslipidemic patients with metabolic syndrome (METS)
Bays, Harold E.
Davies, Michael
Shah, Arvind
MacDonell, Geraldine
Gumbiner, Barry
DIABETES, 2006, 55 : A519 - A519
[6] EFFECTS OF THE TREATMENT WITH EZETIMIBE OR FLUVASTATIN COMPARED WITH EZETIMIBE CO-ADMINISTERED WITH FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
Moriguchi, E. H.
Vieira, J. L.
ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 267 - 267
[7] Ezetimibe co-administered with atorvastatin in 628 patients with primary hypercholesterolemia
Ballantyne, C
Houri, J
Notarbartolo, A
Melani, L
Lipka, L
LeBeaut, A
Suresh, R
Sun, S
Veltri, E
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 227A - 227A
[8] Ezetimibe co-administered with simvastatin in 668 patients with primary hypercholesterolemia
Davidson, M
McGarry, T
Bettis, R
Melani, L
Lipka, L
LeBeaut, A
Suresh, R
Sun, S
Veltri, E
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 226A - 227A
[9] The effects of ezetimibe co-administered with simvastatin on C-reactive protein from a large cohort of hypercholesterolemic patients
Sager, P
Capece, R
Lipka, L
Strony, J
Yang, B
Suresh, R
Mitchel, Y
Veltri, E
CIRCULATION, 2003, 108 (17) : 307 - 307
[10] Review of the consistency of effect of ezetimibe co-administered with statins in patients with primary hypercholesterolemia with or without hypertriglyceridemia
Melani, L
Lipka, L
Lebeaut, A
Suresh, R
Sun, S
Veltri, E
DIABETES, 2002, 51 : A131 - A131

← 1 2 3 4 5 →